JP2001521889A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521889A5
JP2001521889A5 JP2000518654A JP2000518654A JP2001521889A5 JP 2001521889 A5 JP2001521889 A5 JP 2001521889A5 JP 2000518654 A JP2000518654 A JP 2000518654A JP 2000518654 A JP2000518654 A JP 2000518654A JP 2001521889 A5 JP2001521889 A5 JP 2001521889A5
Authority
JP
Japan
Prior art keywords
benzenesulfonamide
pyrazol
trifluoromethyl
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000518654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521889A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/022246 external-priority patent/WO1999022720A2/en
Publication of JP2001521889A publication Critical patent/JP2001521889A/ja
Publication of JP2001521889A5 publication Critical patent/JP2001521889A5/ja
Withdrawn legal-status Critical Current

Links

JP2000518654A 1997-10-31 1998-10-27 早期分娩の治療及び予防中における胎児動脈管の維持にシクロオキシゲナーゼ−２阻害剤を使用する方法 Withdrawn JP2001521889A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6388997P 1997-10-31 1997-10-31
US60/063,889 1997-10-31
PCT/US1998/022246 WO1999022720A2 (en) 1997-10-31 1998-10-27 Selective cyclooxygenase-2 inhibitors against premature labor

Publications (2)

Publication Number Publication Date
JP2001521889A JP2001521889A (ja) 2001-11-13
JP2001521889A5 true JP2001521889A5 (enExample) 2006-01-05

Family

ID=22052179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518654A Withdrawn JP2001521889A (ja) 1997-10-31 1998-10-27 早期分娩の治療及び予防中における胎児動脈管の維持にシクロオキシゲナーゼ−２阻害剤を使用する方法

Country Status (9)

Country Link
EP (1) EP1027048A2 (enExample)
JP (1) JP2001521889A (enExample)
AR (1) AR014000A1 (enExample)
AU (1) AU758566B2 (enExample)
BR (1) BR9813164A (enExample)
CA (1) CA2308639A1 (enExample)
TW (2) TW200404535A (enExample)
WO (1) WO1999022720A2 (enExample)
ZA (1) ZA989876B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152792A0 (en) * 2000-06-08 2003-06-24 Univ Texas Heterocycle derivatives and methods of use
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161789A1 (en) * 1993-05-13 1994-11-24 Jacques Yves Gauthier 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents

Similar Documents

Publication Publication Date Title
JP2004526765A5 (enExample)
RU99110192A (ru) Способ применения ингибиторов циклооксигеназы-2 для лечения и профилактики неоплазии
US5990148A (en) Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6342510B1 (en) Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
US6136839A (en) Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
EP0979077A1 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
KR100765614B1 (ko) 유방염 및 이질환 치료용 분산성 제약 조성물
NZ509755A (en) Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
EP1397145B1 (en) Use of cox-2 inhibitors for the treatment of schizophrenia, or tic disorders
RU2004121147A (ru) Применение ингибиторов сох-2 в сочетании с противовирусными агентами для лечения инфекции вируса папилломы
RU99112952A (ru) Способ применения ингибиторов циклооксигеназы-2 в качестве антиангиогенных средств
JP2004521123A (ja) 腸癌阻害のためのウログアニリンおよびシクロオキシゲナーゼ−２阻害薬の組合わせ
JP2005501850A5 (enExample)
US20020035156A1 (en) Combination therapy in the prevention of cardiovascular disorders
JP2005507871A5 (enExample)
JP2001521889A5 (enExample)
US20040033938A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20070072861A1 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
KR20060033031A (ko) 유선염 및 귀 장애의 치료를 위한 분산성 약학 조성물
JP2005501083A5 (enExample)
AU758566B2 (en) Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor
MXPA99009495A (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
JP2005535657A5 (enExample)
AR020306A1 (es) Composicion terapeutica y su uso como inhibidora de la ciclooxigenasa-2 en la prevencion de alteraciones cardiovasculares.
EP1400242A1 (en) Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor